Just copyin' and pastin'...
"Email exchange from Dr Seymour and a large shareholder. The "To All" is directed to a private group of investors.
----------------------------------
To All:
This is your last chance to obtain shares at these absurd prices, courtesy of the Cabal.
IMO this little 6 month dalliance that Anil conjured working with Jennifer (Dr Moffat) can't possibly extend into April (with a straight face).
Remember, Gene had told Jennifer she must complete her work in three months (by yearend) when she had demanded 6 months.
Those 6 months are now up this week!
I certainly hope this charade ends this week; next Monday is too close to April Fool's day!
That said, when we finally hear the results in a formal PR, I fully expect the stock price to react violently to the upside, as the chart reading suggests.
A Shareholder
----------------------------------------
To All:
Having time to reflect upon Anil and his obsessive quest for perfection, let me restate the obvious:
HE HAS ENORMOUS TROUBLE PERSONALLY MAKING DECISIONS, ESPECIALLY ON THE MAKE-UP OF HIS FIRST PRODUCT.
FOR THAT REASON, AND THAT ONLY, WHEN HE HEARD OF JENNIFER'S MODEL THAT WOULD REPLICATE HUMAN SKIN ON THE BACK OF A MOUSE, HE DECIDED TO DELAY WHAT HE COULD HAVE MADE SIX MONTHS AGO AND FORCE HER TO MAKE IT FOR HIM.
IMO HIS BOD SHOULD NEVER HAVE PUT UP WITH THIS!
SO BE IT!
A Shareholder
-----------------------------------------
Wrong
This was the right move
She’s a world-class scientist who came up with the model
This data will be going to the FDA so it has to be complete!
Remember, as I’ve said many times, it’s one drug that will be administered in different carriers for different herpes diseases
That’s the exciting part!
You don’t demand anything from someone of her caliber, you just politely ask but unfortunately, it takes as long as it takes
The testing system has to be accurate, reliable and reproducible
That’s what she provides!
Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange
-----------------------------------------------
To All:
"....it's ONE DRUG that will be administered in different carriers for different herpes diseases".
"That's the exciting part".
"Different carriers" means different viscosities of skin cream or eye drops, depending on the location on the body.
ONE DRUG FOR ALL 8 forms of Herpes!
FANTASTIC!
A Shareholder
----------------------------------------------
----------------------------------------------
That's all that was posted.
I don't know if this is an interpretation of the large shareholder or a statement from Seymour:
""Different carriers" means different viscosities of skin cream or eye drops, depending on the location on the body.
ONE DRUG FOR ALL 8 forms of Herpes!"
My question, if I was inclined to believe any of that, would be "Does that mean that a single ligand can be designed to treat the nine Herpesviridae that affect humans?"
Because to a simple person like me that seems unlikely. I mean I know that oatmeal does one thing when you eat it and another when you rub it on poison ivy, so I guess it's possible :o)
I was given that information....I don't know.
AI
